Cargando…
Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease
Purpose: To report the 12-month results of the MAJESTIC clinical study of the self-expanding Eluvia paclitaxel-eluting stent in the treatment of femoropopliteal lesions. Methods: The prospective, single-arm, multicenter trial (clinicaltrials.gov identifier NCT01820637) enrolled 57 patients (mean age...
Autores principales: | Müller-Hülsbeck, Stefan, Keirse, Koen, Zeller, Thomas, Schroë, Herman, Diaz-Cartelle, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023034/ https://www.ncbi.nlm.nih.gov/pubmed/27193308 http://dx.doi.org/10.1177/1526602816650206 |
Ejemplares similares
-
Paclitaxel-Coated Balloon for the Treatment of Infrainguinal Disease: 12-Month Outcomes in the All-Comers Cohort of BIOLUX P-III Global Registry
por: Tepe, Gunnar, et al.
Publicado: (2020) -
Drug-Coated Balloon Treatment of Femoropopliteal Lesions Typically Excluded From Clinical Trials: 12-Month Findings From the IN.PACT Global Study
por: Ansel, Gary M., et al.
Publicado: (2018) -
Transradial Approach for Aortoiliac and Femoropopliteal
Interventions: A Systematic Review and Meta-analysis
por: Meertens, Max M., et al.
Publicado: (2018) -
IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population
por: Chen, Zhong, et al.
Publicado: (2019) -
Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease
por: Groot Jebbink, Erik, et al.
Publicado: (2018)